R
44.77
0.38 (0.86%)
| Penutupan Terdahulu | 44.39 |
| Buka | 44.06 |
| Jumlah Dagangan | 76,344 |
| Purata Dagangan (3B) | 1,562,166 |
| Modal Pasaran | 8,273,272,832 |
| Harga / Jualan (P/S) | 10.34 |
| Harga / Buku (P/B) | 5.67 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 24 Feb 2025 - 28 Feb 2025 |
| Margin Operasi (TTM) | -84,595.28% |
| EPS Cair (TTM) | -3.66 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 5.54% |
| Nisbah Semasa (MRQ) | 14.24 |
| Aliran Tunai Operasi (OCF TTM) | -539.71 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -306.13 M |
| Pulangan Atas Aset (ROA TTM) | -28.56% |
| Pulangan Atas Ekuiti (ROE TTM) | -47.18% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Bercampur |
| Biotechnology (Global) | Bercampur | Bercampur | |
| Stok | Revolution Medicines, Inc. | Menaik | Menaik |
AISkor Stockmoo
1.0
| Konsensus Penganalisis | 4.0 |
| Aktiviti Orang Dalam | -3.0 |
| Volatiliti Harga | 2.0 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | -0.5 |
| Purata | 1.00 |
|
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 1.95% |
| % Dimiliki oleh Institusi | 95.21% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 87.00 (Guggenheim, 94.33%) | Beli |
| Median | 68.50 (53.00%) | |
| Rendah | 60.00 (Oppenheimer, 34.02%) | Beli |
| 60.00 (Barclays, 34.02%) | Beli | |
| Purata | 68.63 (53.30%) | |
| Jumlah | 8 Beli | |
| Harga Purata @ Panggilan | 48.98 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Needham | 06 Dec 2024 | 62.00 (38.49%) | Beli | 48.07 |
| 03 Dec 2024 | 68.00 (51.89%) | Beli | 48.23 | |
| Wedbush | 06 Dec 2024 | 67.00 (49.65%) | Beli | 48.07 |
| HC Wainwright & Co. | 04 Dec 2024 | 72.00 (60.82%) | Beli | 48.25 |
| 07 Nov 2024 | 64.00 (42.95%) | Beli | 59.10 | |
| Guggenheim | 03 Dec 2024 | 87.00 (94.33%) | Beli | 48.23 |
| 28 Oct 2024 | 82.00 (83.16%) | Beli | 47.75 | |
| JP Morgan | 03 Dec 2024 | 71.00 (58.59%) | Beli | 48.23 |
| 07 Nov 2024 | 63.00 (40.72%) | Beli | 59.10 | |
| Piper Sandler | 07 Nov 2024 | 70.00 (56.35%) | Beli | 59.10 |
| Oppenheimer | 28 Oct 2024 | 60.00 (34.02%) | Beli | 47.75 |
| Barclays | 27 Sep 2024 | 60.00 (34.02%) | Beli | 44.17 |
| Papar semua | ||||
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| ANDERS JACK | - | 44.71 | -2,635 | -117,811 |
| CISLINI JEFF | - | 44.71 | -1,599 | -71,491 |
| GOLDSMITH MARK A | - | 44.71 | -11,714 | -523,733 |
| HORN MARGARET A | - | 44.71 | -4,329 | -193,550 |
| KELSEY STEPHEN MICHAEL | - | 44.71 | -4,663 | -208,483 |
| Jumlah Keseluruhan Kuantiti Bersih | -24,940 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | -1,115,067 | |||
| Purata Pembelian Keseluruhan ($) | - | |||
| Purata Jualan Keseluruhan ($) | 44.71 | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| GOLDSMITH MARK A | Pegawai | 18 Dec 2024 | Pelaksanaan pilihan | 30,846 | - | - |
| ANDERS JACK | Pegawai | 16 Dec 2024 | Jual automatik (-) | 2,635 | 44.71 | 117,811 |
| CISLINI JEFF | Pegawai | 16 Dec 2024 | Jual automatik (-) | 1,599 | 44.71 | 71,491 |
| KELSEY STEPHEN MICHAEL | Pegawai | 16 Dec 2024 | Jual automatik (-) | 4,663 | 44.71 | 208,483 |
| GOLDSMITH MARK A | Pegawai | 16 Dec 2024 | Jual automatik (-) | 11,714 | 44.71 | 523,733 |
| HORN MARGARET A | Pegawai | 16 Dec 2024 | Jual automatik (-) | 4,329 | 44.71 | 193,550 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2024 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |